Agios Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the Ask Questions tab on the webcast page.
At this time, it is my pleasure to turn the program over to your host, Greg Harrison. You may begin.
Hi, and welcome to the Bank of America SMID Biotech Virtual Conference. I'm Greg Harrison, one of the biotech analysts here at BoA. And today, we're lucky enough to have Agios joining us. Thanks for joining us, everybody. And for those of you out there watching, if you want to send questions, I'm happy to ask on your behalf.
At this time, I'll turn it over to the CEO, Brian Goff, to introduce the team. Brian, if you want to do introductions and start off with some opening remarks, then we can jump into Q&A.
Yes, that's great. And Greg, thanks a lot for hosting us and for the people who have dialed in, thanks so much
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |